En Es
Categories

Industry News


Nova Biomedical Launches New Laboratory Blood Glucose Reference Analyzer

By Labmedica International staff writers
19 Nov 2020

Image: Nova Primary analyzer (Photo courtesy of Nova Biomedical)Nova Biomedical (Waltham, MA, USA) has launched Nova Primary, a rapid, accurate, easy to use, blood glucose laboratory analyzer that fills the need for a new glucose reference analyzer to replace the YSI STAT PLUS 2300 Glucose and L-Lactate analyzer from YSI, Inc., (Yellow Springs, OH, USA).

Manufacturers of blood glucose measuring devices and clinical diabetes researchers have relied on the YSI 2300 as a reference and correlation analyzer. However, as of July 2021, YSI, Inc. is no longer supporting the analyzer, and its discontinuation has left a critical industry void. The Nova Primary analyzer fills that need and will be available for sale in CE regulated countries from January 2021. The Nova Primary was also submitted to the US Food and Drug Administration (FDA) for 510(k) clearance in November 2020 and is anticipated to receive clearance in the first half of 2021.

Similar to the YSI 2300, Nova Primary uses a single, reusable glucose electrochemical sensor based on glucose oxidase and has a measurement range of 10-900 mg/dL. It uses a small, 25 microliter venous whole blood or plasma sample which is internally diluted like the YSI. Results are available in approximately two minutes. Nova Primary’s large color touchscreen display and intuitive, icon-based graphical user interface make it very straightforward to use. A single calibrator pack uses RFID data management to monitor the pack expiration date and number of samples remaining, eliminating the need for separate reagent bottles and daily monitoring of their levels. In clinical laboratory studies using venous whole blood and plasma Nova Primary demonstrated excellent correlation to the YSI 2300 and is traceable to NIST glucose standards.




E-mail Print
FaceBook Twitter Google+ Linked in

Nova Biomedical

Nova is a world leader in the development and manufacturing of whole blood, point-of-care and critical care analyzers. Nova’s biosensor technology is incorporated into products ranging from handheld meters for self- and point-of-care testing to critical care whole blood analyzers designed for rapid measurement of over 20 analytes.
Gold member
More info

More articles about Nova Biomedical

20 Apr 2020
Nova's Stat EMS Basic Blood Testing System Launched in CE Mark Countries
Nova Biomedical (Waltham, MA, USA) has launched the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.
Read More
20 Apr 2020
Nova's Stat Profile Prime Plus Blood Gas Analyzer Receives FDA Clearance for POC Use
Nova Biomedical (Waltham, MA, USA) has secured clearance from the US Food and Drug Administration (FDA) for its Stat Profile Prime Plus critical care blood gas analyzer for point-of-care (POC) use.
Read More
08 Apr 2020
Nova Biomedical Adds PT/INR Test to Allegro Analyzer for POC Testing
Nova Biomedical (Waltham, MA, USA) has added PT/INR testing for its Allegro capillary blood analyzer for point-of-care (POC) testing in primary care settings. With the ability to test for clotting disorders and monitor the effectiveness of blood-thinning medications, the Allegro and its StatStrip-A companion meter provide 18 clinically important tests to help physicians make therapeutic decisions and adjustments at the POC.
Read More
03 Jan 2020
Nova Biomedical Launches New BioProfile FLEX2 On-Line Autosampler
 Nova Biomedical (Waltham, MA, USA) has launched the BioProfile FLEX2 On-Line Autosampler (OLS), a modular system that connects as many as 10 bioreactors to one FLEX2 analyzer for up to three weeks of walkaway, automated sampling, analysis, and feedback control of key cell culture analytes. The FLEX2 measures up to 16 tests, including pH, gases, metabolites, osmolality, cell density, and cell viability.
Read More

Additional news

02 Dec 2020
Hologic Receives FDA Clearance for Genius AI Detection Technology for Early Breast Cancer Detection
Hologic, Inc. (Marlborough, MA, USA) has received US Food and Drug Administration (FDA) clearance for its Genius AI Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.
Read More
12 Nov 2020
Vircell’s Monotest Responds to New Diagnostic Needs for Testing Patients at Risk of Invasive Aspergillosis
A new monotest using chemiluminescence developed by Vircell S.L. (Granada, Spain) could respond to the new diagnostic needs for testing individual samples immediately of patients at risk of invasive aspergillosis, without the need for batching, cumulating samples or sending out to an external laboratory.
Read More
11 Nov 2020
Streck Launches Rapid, Modular qPCR Instrument with Market-Leading Speed
Streck (La Vista, NE, USA) has launched the Zulu RT, a rapid, modular qPCR instrument capable of performing four independent experiments simultaneously. It can perform a 40-cycle, 6-channel 3-step real-time PCR in less than 20 minutes, making it the fastest qPCR instrument in the world.
Read More
10 Nov 2020
COVID-19 Acceleration and Rising Severity Driving Global Ventilator Market
The global ventilator market was valued at USD 11.4 billion in 2019 and has witnessed a growth surge of up to 172% in 2020 as an exponential rise in respiratory infections due to the coronavirus pandemic has accelerated the demand for ventilators across the world.
Read More
06 Nov 2020
Enzo Biochem Launches Portable Microplate Reader for Use with Its ELISA and Assay Kits
Enzo Biochem (New York, NY, USA) has launched a small portable microplate reader for use with the company’s immunoassays and, ultimately, molecular diagnostics, providing new opportunities in point-of-care medicine.
Read More
28 Oct 2020
Randox and Bosch Healthcare Collaboratively Combat COVID-19 with Game-Changing Partnership
The game-changing partnership between Randox Laboratories (Crumlin, UK) and Bosch Healthcare (Waiblingen, Germany) continues to alter the testing landscape and capabilities of both laboratory and non-laboratory settings for rapidly detecting COVID-19.
Read More
20 Oct 2020
Mindray Hematology Solution Helps High-Volume Lab Run 2,820,000 CBC Tests Annually
High-volume laboratories face several challenges, including high instrument failure rate, errors due to several manual steps, low efficiency and long TAT, and heavier workload for the lab staff.
Read More
23 Sep 2020
AI in Medical Imaging to Reach USD 1.5 Billion by 2024
The global market for AI-based clinical applications for use in medical imaging is set to reach almost USD 1.5 billion by 2024 despite a slower-than-expected uptake of these products and the impact of the COVID-19 pandemic.
Read More
16 Sep 2020
MEDICA and COMPAMED 2020 to Take Place Entirely Online From 16-19 November 2020
MEDICA 2020 and COMPAMED 2020, both leading information and communication platforms for the medical technology industry and supplier industry for the medical technology industry, will take place entirely online from 16 to 19 November.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions